Observatory of the Treatment of Ambulatory Patients with Cardiac Failure: Results of an Enquiry amongst Cardiologists;Observatoire de la prise en charge de l'insuffisance cardiaque en ambulatoire: Enquête auprès des cardiologues

Archives des Maladies du Coeur et des Vaisseaux

Volumn 94, Issue 4, 2001, Pages 257-261

  Komajda, M ^a   Bouhour, J B ^b   Amouyel, P ^c   Delahaye, F ^d   Vicaut, E ^e   Croce, I ^f   Rougemond, E ^f   Vuittenez, F ^g   Leutenegger, E ^f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d LOUIS PRADEL HOSPITAL   (France)

^e HÔPITAL FERNAND WIDAL   (France)

^f Groupe Lipha   (France)

^g MediSCAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGE; AGED; ARTICLE; CARDIOLOGY; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PATHOLOGY;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOLOGY; CARDIOTONIC AGENTS; DIGITALIS GLYCOSIDES; DIURETICS; FEMALE; HEALTH SURVEYS; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS;

EID: 0035321097     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Pousset F. Insuffisance cardiaque : prise en charge thérapeutique. Lettre Pharmocol (suppl), sept. 1999.
2. Giles T. Enalapril in the treatment of congestive heart failure. J Cardiovasc Pharmocol 1990 ; suppl. 15 : 6-10.
3. Erhardt LR, Cline CMJ. Organisation of the care of patients with heart failure. Lancet 1998 ; suppl 352 : 15-8.
4. Delahaye F, De Gevigney G, Gaillard S, Cheneau E. Épidémiologie et impact économique de l'insuffisance cardiaque en France. Arch Mal Cœur 1998 ; 91 : 1307-145.
5. Andrews R, Cowley AJ. Clinical and economic factors in the treatment of congestive heart failure. Pharmacoeconomics 1995; 7 : 119-27.
6. Levy E. From cost if illness to cost-effectiveness in heart failure. Eur Heart J 1998 ; 19 : 2-4.
7. Giles TD. Optimizing the treatment of heart failure. Curr Opin Cardiol 1994 ; suppl. 9 : 21-7.
8. Eichhorn EJ. Experience with beta blokers in heart failure mortality trials. Clin Cardiol 1999; suppl. 22 : 21-9.
9. Studies of left ventricular dysfunction (SOLVD) Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991 ; 325 : 293-302.
10. Consensus Trial study group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1249-35.
11. Report of the American college of cardiology/American heart association task-force on practice guidelines (Committee on evaluation and management of heart failure) Guidelines for the evaluation and management of heart failure. Circulation 1995; 92: 2764-84.
12. The task force of the working group on heart failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997 ; 18 : 736-53.
13. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol 1997 ; 30 : 518-6.
14. Philbin EF. Factors determining angiotensin-converting enzyme inhibitor underutilisation in heart failure in a community setting. Clin Cardiol 1998 ; 21 : 103-8.
15. Andersson F, Cline C, Ryden-Bergsten T, Erhardt L. Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing. Pharmacoeconomics 1999 ; 15 : 535-50.
16. Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med 1997 ; 157 : 2242-7.
17. Von Vedhuissen DJ, Charlesworth A, Crijns HJ, Hampton JR. Differences in drug treatment of chronic heart failure between European countries. Eur Heart J 1999 ; 20 : 666-72.
18. Childs M, Cayet J, Desnoyers E, Lagente JL. Les observatoires de la prise en charge du patient atteint d'une pathologie (ORP) : vers l établissement de nouveaux standards méthodologiques. Lettre Pharmacol 1999 ; 13 : 90-2.
19. Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G for the Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology the National College of General Hospital Cardiologists and the French Geriatrics Society. A national survey of heart failure in French hospitals. Eur Heart J 2000 ; 21 : 763-9.
20. Reitsma JB, Mosterd A, De Craen AJM and al. Increase in hospital admissions rates for heart failure in the Netherlands, 1980-1993. Heart 1996 ; 76 : 388-92.
21. Cline C, Brows K, Willenheimer R, Israelsson B, Erhardt L. Hospitalization and health care costs due to congestive heart failure in the elderly. Am J Geriatr Cardiol 1996 ; 5 : 10-23.
22. Opasich C, Febo O, Ricardi G et al. Concomitant factors of decompensation in chronic heart failure. Am J Cardiol 1996 ; 78 : 345-57.
23. Ghali JK, Kadakia S, Cooper R, Ferlinz. Precipating factors leading to decompensation of heart failure. Arch intern Med 1908; 148 : 2013-16.
24. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990 ; 38 : 1290-5.
25. Young JB. Angiotensin-converting enzyme inhibitors in heart failure : new strategies justified by recent clinical trials. Int J Cardiol 1994 ; 43 : 151-63.
26. Parmley WW. Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection. Am J Med 1998 ; 105 : 27S-31S.
27. Struthers AD. Rationalizing the heart failure trials: from theory to practice. Eur Heart J 1997 ; 18 (suppl E) : E5-E8.
28. McMurray JJ. Failure to practice evidence-based medicine : why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? Eur Heart J 1998 ; 19 (suppl L) : L15-L21.
29. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999 ; 353 (9146) : 9-13.
30. Sackner-Bernstein JD. Use of carvedilol in chronic heart failure : challenges in their management. Prog Cardiovasc Dis 1998 ; 41 (suppl. 1) : 53-8.